leflunomide and Ischemic Attack, Transient
leflunomide has been researched along with Ischemic Attack, Transient in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Navarro, CE | 1 |
Enríquez-Ruano, P | 1 |
Enríquez-Ruano, MN | 1 |
Other Studies
1 other study available for leflunomide and Ischemic Attack, Transient
Article | Year |
---|---|
Leflunomide-induced recurrent-transient ischaemic attacks in a patient with rheumatoid arthritis: first case report.
Topics: Aged, 80 and over; Arthritis, Rheumatoid; Humans; Immunosuppressive Agents; Ischemic Attack, Transie | 2020 |